Climb Bio (CLYM) Share-based Compensation (2020 - 2026)

Climb Bio (CLYM) has 7 years of Share-based Compensation data on file, last reported at $1.6 million in Q1 2026.

• Quarterly Share-based Compensation fell 20.62% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.5 million (up 75.4% YoY) and the FY2025 annual result came in at $11.7 million, up 110.55% from the prior year.
• Share-based Compensation slipped to $1.6 million in Q1 2026, from $7.8 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $10.2 million in Q3 2025 to a low of $313000.0 in Q1 2023.
• A 5-year average of $2.3 million and a median of $1.6 million in 2022 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation jumped 418.86% — and 2023, when it sank 79.69%.
• Tracing CLYM's Share-based Compensation over 5 years: stood at $1.8 million in 2022, then sank by 32.59% to $1.2 million in 2023, then surged by 37.94% to $1.7 million in 2024, then surged by 372.74% to $7.8 million in 2025, then slumped by 79.52% to $1.6 million in 2026.
• The last three Share-based Compensation figures came in at $1.6 million (Q1 2026), $7.8 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.